Retrospective case-series of Paecilomyces lilacinus ocular mycoses in Queensland, Australia

BMC Research Notes

Diana Conrad¹  Liam Daniel Turner¹ 

[1]Ophthalmology Department, The Royal Brisbane and Women’s Hospital, 10/87 Hampstead Road, Highgate Hill, Brisbane 4101, QLD, Australia

关键词: Voriconazole;    Paecilomyces;    Fungal infection;   

Others  :  1232871
DOI  :  10.1186/s13104-015-1591-0

 received in 2014-12-18, accepted in 2015-10-14,  发布年份 2015

【 摘 要 】

Background

The purpose of this study was to report: (1) the varying presentation of Paecilomyces ocular infections arising in Queensland; (2) the significance of immunosuppression as a primary determinant of disease; (3) the outcomes of voriconazole use; and (4) the ongoing need for both surgical and medical management of this devastating fungal infection.

Methods

A retrospective case series of 21 culture proven individuals participated in this series and were identified via a review of the pathology reporting system utilized in the Queensland public health system. All culture proven individuals were subjected to a systematic chart review.

Results

The primary risk factor for Paecilomyces lilacinus infection is immunosuppression with 81.25 % of individuals being on some form of immunosuppression (i.e. systemic or topical). Of the cases 71.43 % had an intact epithelial surface at the time of diagnosis, and 76 % had no previous ocular history. The final visual outcomes were nine cases with HM vision or worse, three cases with 6/48–6/60 vision, three cases 6/12–6/24, and six cases with 6/12 vision or better. Despite voriconazole use rates of greater than 80 %, protracted and poor treatment outcomes continue to be commonplace.

Conclusions

Paecilomyces lilacinus is a filamentous fungus that has a predilection for immunosuppressed individuals. Despite in vitro and case reports demonstrating the effectiveness of voriconazole poor outcomes continue to be seen.

【 授权许可】

   
2015 Turner and Conrad.

【 参考文献 】

• [1]Chang B, Sun PL, Huang FY, Tsai TC, Lin CC, Lee MD, Chen YC, Sheu JC, Tsai JD: Paecilomyces lilacinus perotinitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy. J Med Microbiol 2008, 57:1581-1584.
• [2]Ezzedine K, Belin E, Guillet S, Almeida MD, Droitcourt C, Accocebery I, Milpied B, Jouary T, Malvy D, Taieb A: Cutaneous hyphomycosis due to Paecilomyces lilacinus. Acta Dermato-Venereol 2012, 92:156-192.
• [3]Jacobs H, Gray SN, Crump DH: Interactions between nematogenous fungi and consequences for their potential as biological agents for the control of potato cyst nematodes. Mycol Res 2003, 107:47-56.
• [4]Keshtkar-Jahromi M, McTighe AH, Segalman KA, Fothergill AW, Campbell WN: Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voricobazole and review of published literature. Myopathologia. 2012, 174:255-258.
• [5]Anderson K, Mitra S, Salouti R, Pham TA, Taylor HR: Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea 2004, 23(5):516-521.
• [6]Castelli M, Alastruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodrigues-Tudela JL, Cuenca-Estrella M: Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother 2008, 52(8):2926-2928.
• [7]Pastor F, Guarro J: Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006, 12:948-960.
• [8]Chan-Tack K, Thio CL, Miller NS, Karp CL, Ho C, Merz WG: Paecilomyces lilacinus fungaemia in an adult bone marrow transplant recipient. Med Mycol 1999, 37:57-60.
• [9]Ciecko SC, Scher R: Invasive fungal rhinitis caused by Paecilomyces lilacnus infection: report of a case and a novel treatment. ENT J. 2010, 89(12):594-595.
• [10]dos Santos Brito M, da Silva Lima M, Morgado FN, Raibolt P, Menezes R, Conceicao-Silva F, de Moraes Borba C: Characteristics of Paecilomyces lilacinus infection comparing immunocompetent with immunosuppressed murine model. Mycoses 2011, 54:513-521.
• [11]Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC: Paecilomyces lilacinus infection in a liver transplant patient: a case report and review of the literature. Transpl Infect Dis 2008, 10:117-122.
• [12]Yuan X, Wilhelmus KR, Matoba AY, Alexandrakis G, Miller D, Huang AJW: Pathogenesis and outcome of paecilomyces keratitis. Am J Ophthalmol 2009, 147(4):691-696.
• [13]Stephan Z, Al-Din SS: Influence of temperature and culture media on the growth of fungus Paecilomyces lilacinus. Revue de Nematol 1987, 10:494.
• [14]Ali T, Amescua G, Miller D, Suh LH, Delmonte DW, Gibbons A, Alfonso EC, Forster RK. Contact-lens-associated Purpureocillium keratitis: risk factors, microbiologic characteristics, clinical course, and outcomes. Semin Ophthalmol. 2015:1–6.
• [15]Pettit T, Olson RJ, Foos RY, Martin WJ: Fungal endophthalmitis following intraocular lens implantation: a surgical epidemic. Arch Ophthalmol 1980, 98:1025-1039.
• [16]O’Day D: Fungal endophthalmitis caused by Paecilomyces lilacinus after intraocular lens implantation. Am J Ophthalmol 1977, 83:130-131.
• [17]Hirst L, Sebban A, Whitby RM, Nimmo GR, Stallard K: Non-traumatic mycotic keratitis. Eye. 1992, 6:391-395.
• [18]McLintock C, Lee GA, Atkinson G: Management of recurrent Paecilomyces lilacinus keratitis. Clin Exp Optom 2012, 96:343-345.
• [19]Mizunoya S, Watanabe Y: Paecilomyes keratitis with corneal perforation salvaged by a conjunctival flap and delayed keratoplasty. Br J Ophthalmol 1994, 78:157-158.
• [20]Okhravi N, Dart JK, Towler HM, Lightman S: Paecilomyces lilacinus endophthalmitis with secondary keratitis. Arch Ophthalmol 1997, 115:1320-1324.
• [21]Chung P, Lin HC, Hwang YS, Tsai YJ, Ngan KW, Huang SCM, Hsiao CH: Paecilomyces lilacinus scleritis with secondary keratitis. Cornea 2007, 26:232-234.
• [22]Hirst L, Choong K, Playford EG: Nontraumatic paecilomyces anterior segment infection: a pathognomonic clinical appearance. Cornea 2014, 33(10):1031-1037.
• [23]Okhravi N, Lightman S: Clinicial manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2007, 13(5):554.
• [24]Shing M, Ip M, Li CK, Chik KW, Yuen PM: Paecilomyces variotii fungemia in an adult bone marrow transplant recipient. Bone Marrow Transpl 1996, 17:281-283.
• [25]Lee G, Whitehead K, McDougall R: Management of Paecilomyces keratitis. Eye. 2007, 21:262-264.
• [26]Sponsel W, Chen N, Dang D, Paris G, Graybill J, Najvar LK, Zhou L, Lam KW, Glickman R, Scribbick F: Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother 2006, 50:262-268.
• [27]Pujol I, Aguilar C, Ortoneda M, et al.: Experimental pathogenesis of three opportunistic Paecilomyces species in a murine model. J Med Mycol 2002, 12:86-89.
• [28]Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J: In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother 2004, 48:2727-2729.
• [29]Ford J, Agee S, Greenshaw ST: Successful medical treatment of a case of Paecilomyces lilacinus keratitis. Cornea 2008, 27:1077-1079.
• [30]Arnoldner M, Kheirkhan A, Jakobiec FA, Durand ML, Hamrah P: Successful treatment of Paecilomyes lilacinus keratitis with oral posaconazole. Cornea 2014, 33(7):747-749.
• [31]Monden Y, Sugita M, Yamakawa R, Nishimura K: Clinical experience treating Paecilomyces lilacinus keratitis in four patients. Clin Ophthalmol 2012, 6:949-953.
• [32]Deng S, Kamal KM, Hollander DA: The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis. J Ocul Pharmacol Ther 2009, 25(2):175-177.
• [33]Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rohner P: Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002, 34:701-703.
• [34]Yildiz E, Ailani H, Hammersmith KM, Eagle RC, Rapuano CJ, Cohen EJ: Alternaria and paecilomyces keratitis associated with soft contact lens wear. Cornea 2010, 29:564-568.
• [35]Wu P, Lai CH, Tan HY, Ma DHK, Hsiao CH: The successful medical treatment of a case of Paecilomyces lilacinus keratitis. Cornea 2010, 29:357-358.